Resolution, absolute stereochemistry and molecular pharmacology of the enantiomers of ATPA

European Journal of Pharmacology

Volumn 380, Issue 2-3, 1999, Pages 153-162

  Stensbøl, Tine B ^a   Borre, Lars ^b   Johansen, Tommy N ^a   Egebjerg, Jan ^b   Madsen, Ulf ^a   Ebert, Bjarke ^a   Krogsgaard Larsen, Povl ^a  

^a PharmaBiotec Neurosci Res Center   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

AMPA (2 amino 3 (3 hydroxy 5 methyl 4 isoxazolyl)propionic acid); AMPA receptor cloned; ATPA (2 amino 3 (5 tert butyl 3 hydroxy 4 isoxazolyl)propionic acid); Chiral chromatography; Cortical wedge preparation; Enantiomer; Kainate receptor cloned; Kainic acid; Rat

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR; KAINIC ACID RECEPTOR;

ANIMAL TISSUE; ARTICLE; BRAIN; CHIRAL CHROMATOGRAPHY; CONFORMATION; CONTROLLED STUDY; ENANTIOMER; LIGAND BINDING; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; STEREOCHEMISTRY; STRUCTURE ACTIVITY RELATION;

ANIMALS; BINDING, COMPETITIVE; CEREBRAL CORTEX; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHYSIOLOGY; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; ISOXAZOLES; MOLECULAR CONFORMATION; OOCYTES; PROPIONATES; QUINOXALINES; RADIOLIGAND ASSAY; RATS; RECEPTORS, AMPA; RECOMBINANT FUSION PROTEINS; STEREOISOMERISM; TRITIUM; XENOPUS;

EID: 0032872268     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00512-9     Document Type: Article

References (37)

1. Armstrong D.W., Liu Y., Ekborgott K.H. A covalently bonded teicoplanin chiral stationary phase for HPLC enantioseparations. Chirality. 7:1995;474-497.
2. Arnt J., Sánchez C., Lenz S.M., Madsen U., Krogsgaard-Larsen P. Differentiation of in vivo effects of AMPA and NMDA receptor ligands using drug discrimination methods and convulsant/anticonvulsant activity. Eur. J. Pharmacol. 285:1995;289-297.
3. Berthod A., Liu Y., Bagwill C., Armstrong D.W. Facile liquid chromatographic enantioresolution of native amino acids and peptides using teicoplanin chiral stationary phase. J. Chromatogr. 731:1996;123-137.
4. Bettler B., Boulter J., Hermans-Borgmeyer I., O'Shea-Greenfield A., Deneris E.S., Borgmeyer U., Hollmann M., Heinemann S. Cloning of a novel glutamate receptor subunit, GluR5: expression in the nervous system during development. Neuron. 5:1990;583-595.
5. 3H ]kainic acid receptor binding by divalent cations correlates with ion affinity for the calcium channel Neuropharmacology. 26:1987;1247-1251.
6. Chittajallu R., Braithwaite S.P., Clarke V.R.J., Henley J.M. Kainate receptors: subunits, synaptic localization and function. Trends Pharmacol. Sci. 20:1999;26-35.
7. Clarke V.R.J., Ballyk B.A., Hoo K.H., Mandelzys A., Pellizzari A., Bath C.P., Thomas J., Sharpe E.F., Davies C.H., Ornstein P.L., Schoepp D.D., Kamboj R.K., Collingridge G.L., Lodge D., Bleakman D. A hippocampal GluR5 kainate receptor regulating inhibitory synaptic transmission. Nature. 389:1997;599-603.
8. Collingridge, G., Watkins, J.C., 1994. The NMDA Receptor. Oxford Univ. Press, Oxford.
9. Conn P.J., Pin J.-P. Pharmacology and functions of metabotropic glutamate receptors. Ann. Rev. Pharmacol. Toxicol. 37:1997;205-237.
10. Curry K., Pajouhesh H. Pharmacological profile of the isomers of the GluR-specific agonist ATPA. Can. J. Physiol. Pharmacol. 76:1998;690-692.
11. Danysz W., Parsons C.G., Bresink I., Quack G. Glutamate in CNS disorders. Drug News & Perspect. 8:1995;261-277.
12. Ebert B., Madsen U., Lund T.M., Holm T., Krogsgaard-Larsen P. Molecular pharmacology of cortical and spinal AMPA receptors. Mol. Neuropharmacol. 2:1992;47-49.
13. Falch E., Brehm L., Mikkelsen I., Johansen T.N., Skjærbæk N., Nielsen B., Stensbøl T.B., Ebert B., Krogsgaard-Larsen P. Heteroaryl analogues of AMPA: 2. Synthesis, absolute stereochemistry, photochemistry and structure-activity relationships. J. Med. Chem. 41:1998;2513-2523.
14. Gübitz G., Jellenz W., Santi W. Resolution of the optical isomers of underivatisized amino acids on chemically bound chiral phases by ligand exchange chromatography. J. Liq. Chromatogr. 4:1981;701-712.
15. Gübitz G., Jellenz W., Santi W. Resolution of the optical isomers of amino acids by ligand-exchange chromatography using chemically bonded chiral phases. J. Chromatogr. 203:1981;377-384.
16. Harrison N.L., Simmonds M.A. Quantitative studies on some antagonists of N-methyl-D-aspartate in slices of rat cerebral cortex. Br. J. Pharmacol. 84:1985;381-391.
17. Hollmann M., Heinemann S. Cloned glutamate receptors. Annu. Rev. Neurosci. 17:1994;31-108.
18. Honoré T., Nielsen M. Complex structure of quisqualate-sensitive glutamate receptors in rat cortex. Neurosci. Lett. 54:1985;27-32.
19. 3H -CNQX binds with equal affinity to two agonist states of quisqualate receptors Biochem. Pharmacol. 38:1989;3207-3212.
20. Johansen T.N., Ebert B., Falch E., Krogsgaard-Larsen P. AMPA receptor agonists: resolution, configurational assignment, and pharmacology of (+)-(S)- and (-)-(R)-2-amino-3-[3-hydroxy-5-(2-pyridyl)-isoxazol-4-yl]-propionic acid (2-Py-AMPA). Chirality. 9:1997;274-280.
21. Knöpfel T., Kuhn R., Allgeier H. Metabotropic glutamate receptors: novel targets for drug development. J. Med. Chem. 38:1995;1417-1426.
22. Krogsgaard-Larsen P., Hansen J.J., Lauridsen J., Peet M.J., Leah J.D., Curtis D.R. Glutamic acid agonists, stereochemical and conformational studies of DL-α-amino-3- hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and related compounds. Neurosci. Lett. 31:1982;313-317.
23. Krogsgaard-Larsen P., Ebert B., Lund T.M., Bräuner-Osborne H., Sløk F.A., Johansen T.N., Brehm L., Madsen U. Design of excitatory amino acid receptor agonists, partial agonists and antagonists: ibotenic acid as a key lead structure. Eur. J. Med. Chem. 31:1996;515-537.
24. Lauridsen J., Honoré T., Krogsgaard-Larsen P. Ibotenic acid analogues. Synthesis, molecular flexibility, and in vitro activity of agonists and antagonists at central glutamic acid receptors. J. Med. Chem. 28:1985;668-672.
25. Leatherbarrow, R.J., 1992. GraFit version 3.0. Erithacus Software, Staines, U.K.
26. + channel determined by construction of multimeric cDNAs. Neuron. 9:1992;671-861.
27. Madsen U., Frølund B., Lund T.M., Ebert B., Krogsgaard-Larsen P. Design, synthesis and pharmacology of model compounds for indirect elucidation of the topography of AMPA receptor sites. Eur. J. Med. Chem. 28:1993;791-800.
28. Monaghan, D.T., Wenthold, R.J. 1997. The Inotropic Glutamate Receptors. Humana Press, Totowa, NJ.
29. 3H ]3-(2-carboxypiperazin-4yl)propyl-1-phosphonic acid to rat brain membranes: a selective, high-affinity ligand for N-methyl-D-aspartate receptors J. Pharmacol. Exp. Ther. 240:1987;778-784.
30. Møller E.H., Egebjerg J., Brehm L., Stensbøl T.B., Johansen T.N., Madsen U., Krogsgaard-Larsen P. Resolution, absolute stereochemistry, and enantiopharmacology of the GluR1-4 and GluR5 antagonist 2-amino-3-(5-tert-butyl-3-(phosphonomethoxy)-4-isoxazolyl)propionic acid. Chirality. 11:1999;. in press.
31. 3H ]MK-801 binding to the N-methyl-D-aspartate receptor ion channel complex by L-glutamate, glycine and polyamines J. Neurochem. 51:1988;830-836.
32. Schild H.O. pA, A new scale for the measurement of drug antagonism. Br. J. Pharmacol. 2:1947;189-206.
33. Sløk F.A., Ebert B., Lang Y., Krogsgaard-Larsen P., Lenz S.M., Madsen U. Excitatory amino-acid receptor agonists. Synthesis and pharmacology of analogues of 2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid. Eur. J. Med. Chem. 32:1997;329-338.
34. Sommer B., Burnashev N., Verdoorn T.A., Kainanen K., Sakmann B., Seeburg P.H. A glutamate receptor channel with high affinity for domoate and kainate. EMBO J. 11:1992;1651-1656.
35. Turski L., Jacobsen P., Honoré T., Stephens D.N. Relief of experimental spasticity and anxiolytic/anticonvulsant actions of the α-amino-3-hydroxy-5-methyl-4-isoxazole-propionate antagonist 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(F)quinoxaline. J. Pharmacol. Exp. Ther. 260:1992;742-747.
36. Wahl P., Frandsen A., Madsen U., Schousboe A., Krogsgaard-Larsen P. Pharmacology and toxicology of ATOA, an AMPA receptor antagonist and a partial agonist at GluR5 receptors. Neuropharmacology. 37:1998;1205-1210.
37. Wheal, H.V., Thomson, A.M., 1995. Excitatory Amino Acids and Synaptic transmission. Academic Press, London.